MA42681B1 - Inhibiteurs de l'ezh2 - Google Patents
Inhibiteurs de l'ezh2Info
- Publication number
- MA42681B1 MA42681B1 MA42681A MA42681A MA42681B1 MA 42681 B1 MA42681 B1 MA 42681B1 MA 42681 A MA42681 A MA 42681A MA 42681 A MA42681 A MA 42681A MA 42681 B1 MA42681 B1 MA 42681B1
- Authority
- MA
- Morocco
- Prior art keywords
- compounds
- ezh2 inhibitors
- tumors
- ezh2
- enhancer
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 3
- 102000058017 Enhancer of Zeste Homolog 2 Human genes 0.000 abstract 2
- 101710196274 Histone-lysine N-methyltransferase EZH2 Proteins 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002489 hematologic effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La présente invention concerne des composés qui inhibent l'activité de l'histone lysine n-méthyltransférase ezh2 (enhancer of zeste homolog 2), des compositions pharmaceutiques comprenant ces composés, et des méthodes d'utilisation de ces composés pour traiter le cancer, par exemple les tumeurs hématologiques et les tumeurs solides.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15382433 | 2015-08-27 | ||
| PCT/US2016/047989 WO2017035060A1 (fr) | 2015-08-27 | 2016-08-22 | Inhibiteurs de l'ezh2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA42681B1 true MA42681B1 (fr) | 2020-01-31 |
Family
ID=54145713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA42681A MA42681B1 (fr) | 2015-08-27 | 2016-08-22 | Inhibiteurs de l'ezh2 |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR105666A1 (fr) |
| MA (1) | MA42681B1 (fr) |
-
2016
- 2016-08-10 AR ARP160102455A patent/AR105666A1/es unknown
- 2016-08-22 MA MA42681A patent/MA42681B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR105666A1 (es) | 2017-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020013649A (es) | Composiciones y metodos para inhibir la actividad de la arginasa. | |
| EA201591823A1 (ru) | Ингибиторы ido | |
| MX2017012730A (es) | Inhibidores de indolamina 2,3-dioxigenasa (ido) para el tratamiento de cancer. | |
| PH12018500423A1 (en) | Inhibitors of ezh2 | |
| MX366875B (es) | Inhibidores de indoleamina 2,3-dioxigenasa (ido). | |
| MX2016002075A (es) | Inhibidores de indolamina 2,3-dioxigenasa (ido). | |
| EA201591599A1 (ru) | Ингибиторы ido | |
| MX2015017486A (es) | Inhibidores de indolamina 2,3-dioxigenasa (dio). | |
| EA201891057A1 (ru) | Композиции и способы для ингибирования активности аргиназы | |
| MX373373B (es) | Inhibidores de desmetilasa-1 específica de lisina. | |
| JOP20210158A1 (ar) | مُعَدِّلات التعبير الجيني عن hsd17b13 | |
| MA47736B1 (fr) | Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1 | |
| MX2017015923A (es) | Inhibidores de indolamina-2,3-dioxigenasa (ido). | |
| MA43052B1 (fr) | Inhibiteurs de la kallicréine plasmatique humaine | |
| MA42681B1 (fr) | Inhibiteurs de l'ezh2 | |
| MA43158B1 (fr) | Composés oxa-diazadispiro possédant une activité contre la douleur | |
| EA202190125A1 (ru) | ПРОИЗВОДНЫЕ ПИРИДОПИРИМИДИНОНА ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Axl | |
| EA202191138A1 (ru) | Композиции и способы для ингибирования активности аргиназы | |
| EA201991517A1 (ru) | Композиции и способы ингибирования активности аргиназы | |
| EA201892527A1 (ru) | Ингибиторы энхансера гомолога 2 белка zeste |